MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer’s Disease

Abstract

CSF miRNAs can discriminate AD from controls. Combining miRNAs improves sensitivity and specificity of biomarker performance, and adding ApoE genotype improves classification.